COHEN NEIL HARRIS

PrivateCIK: 1840006
Location

CAMBRIDGE, MA

COHEN NEIL HARRIS (interim CEO) purchased 19.2% of their position (2K shares) of CHEMOMAB THERAPEUTICS LTD. on the open market

Open‑market purchase worth $6.4K — a significant purchase. The strongest form of insider conviction signal.

P · 1 purchase
InsiderCOHEN NEIL HARRISCIK 1840006
DirectorOfficer· interim CEO
Since Apr 2020
+21.39K
Net shares
Net buyer
$6.4K
Total acquired
1
Open market trades
1B · 0S
4
Total transactions
21.39K acquired
Non-Derivative Transactions1

American Depositary Shares

Direct
P · Purchase

Shares

+2K

Price / share

$3.19

Trade value

$6.38K

% of position

19.2%
5/18/2022
10.41K12.41K
Total

Net shares

+2K

Net value

$6.38K

Derivative Transactions3

Option to Purchase American Depositary Shares

Direct
A · Award
Converts to

American Depositary Shares

688.00 shares

Shares

+688.00

Strike price

13.17

Held after

688.00

Exercisable

3/16/2021

Option to Purchase American Depositary Shares

Direct
A · Award
Converts to

American Depositary Shares

11.88K shares

Shares

+11.88K

Strike price

27.26

Held after

11.88K

Exercisable

4/19/2021

Option to Purchase American Depositary Shares

Direct
A · Award
Converts to

American Depositary Shares

6.82K shares

Shares

+6.82K

Strike price

3.53

Held after

6.82K

Exercisable

3/7/2022
COHEN NEIL HARRIS — Insider Transaction (Form 4) Filed May 19, 2022 | Finecho